The Food and Drug Administration (FDA) has issued Pfizer’s COVID-19 vaccine’s booster shot for children as young as 12 years of age. The Pfizer vaccine has become the first booster shot to get approval from the FDA for children.
The Pfizer vaccine was approved to be used for adolescents in May. Later, the CDC (Centre for Disease Control and Prevention) recommended adults seek a booster shot six months after their second and final dose.
After becoming the first vaccine to receive emergency authorization for young and pre-teens, the Pfizer vaccine will roll out its booster shots for teens very soon. This means that the teens are immediately eligible to receive the booster shot.
The FDA came up with the move after the recent high surge in the Covid cases in the U.S. The United States of America is dealing with a rapid rise in Covid-19 cases caused by the highly contagious omicron variant.
The new Omicron variant is slightly more resistant to vaccines, and the booster shots are expected to offer significantly better protection against any severe complications or death resulting from Covid.
The Omicron variant’s spread has also caused havoc in other parts of the world. A very high transmission rate has resulted in the quick spread of the variant and the surge in the Covid-19 cases in many countries.
At the time of writing, Pfizer Inc. (PFE) stock traded at $57.19, down 1.86 points (-3.15%).
